Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
A cellular epigenetic classification system for glioblastoma.
PMID 41499453 · PMC13128495 · Neuro-oncology · 2026 · 8 claims · 8 setups
ITHresolveGBM, a hierarchical two-step NMF method, deconvolutes bulk GBM DNA methylation profiles into three non-malignant (immune, glial, neuronal) and three malignant components
-
Full-text index only
Cancer genome standards for long-read sequencing using cancer cell line mixtures.
PMID 41934171 · PMC13137868 · GigaScience · 2026 · 8 claims · 6 setups
Long-read variant calling tools achieve recall rates comparable to short-read gold standards
-
Full-text index only
Glioblastoma stem cells show transcriptionally correlated spatial organization.
PMID 41577992 · PMC12894897 · Communications biology · 2026 · 8 claims · 5 setups
GSCs from different patient samples exhibit diverse, characteristic multicellular spatial patterns in culture (e.g., anisotropic vs isotropic packing, overlapping vs non-overlapping space utilization)
-
Has reproduction
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning.
PMID 36611079 · PMC9825621 · NPJ precision oncology · 2023 · 8 claims · 8 setups
Tree-based (XGBoost, LightGBM) and deep-learning (TabNet) tabular ML classifiers achieve state-of-the-art somatic vs germline classification in tumor-only WES samples, outperforming PureCN.
-
Has reproduction · 82
Landscape of allele-specific transcription factor binding in the human genome.
PMID 33980847 · PMC8115691 · Nature communications · 2021 · 8 claims · 6 setups
A novel statistical framework (ADASTRA) calls allele-specific TF binding from existing ChIP-Seq alignments by jointly correcting for background allelic dosage (BAD, from aneuploidy/CNVs) and reference mapping bias.